scholarly article | Q13442814 |
P50 | author | Patrick Emmet Duffy | Q7146446 |
David L. Narum | Q55174557 | ||
Michal Juraska | Q56776179 | ||
Sebastian Ols | Q56776192 | ||
Kazutoyo Miura | Q66876252 | ||
Carole A Long | Q66908908 | ||
Kelly M. Rausch | Q114406011 | ||
P2093 | author name string | Mats Spångberg | |
Elizabeth A Thompson | |||
Lloyd Johnston | |||
Randall F Howard | |||
Karin Loré | |||
Ulrike Wille-Reece | |||
Conlin P O'Neil | |||
Amy Weiner | |||
P2860 | cites work | Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. | Q37773425 |
Phenotype and functions of memory Tfh cells in human blood | Q38226748 | ||
Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses | Q38349570 | ||
The march toward malaria vaccines | Q38577638 | ||
Non-human primates as a model for understanding the mechanism of action of toll-like receptor-based vaccine adjuvants. | Q39439099 | ||
Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques | Q40077472 | ||
Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake. | Q40180898 | ||
Systems analysis of protective immune responses to RTS,S malaria vaccination in humans | Q40334346 | ||
Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infection | Q40681333 | ||
Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions | Q40822910 | ||
Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells | Q44471210 | ||
Duration of humoral immunity to common viral and vaccine antigens | Q45872621 | ||
Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells. | Q47112853 | ||
Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells | Q47875310 | ||
Reference values of clinical chemistry and hematology parameters in rhesus monkeys (Macaca mulatta). | Q53752989 | ||
IFN-alpha/beta enhances BCR-dependent B cell responses | Q77885633 | ||
Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation | Q85052394 | ||
Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs | Q89777595 | ||
Advances and challenges in malaria vaccine development | Q21032463 | ||
Self-assembling protein nanoparticles in the design of vaccines | Q26767097 | ||
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans | Q29616204 | ||
Programming the magnitude and persistence of antibody responses with innate immunity | Q30400144 | ||
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. | Q33350210 | ||
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. | Q33760871 | ||
Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle | Q34341570 | ||
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization | Q34509612 | ||
Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays | Q34618434 | ||
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance | Q34985424 | ||
Vaccine-induced plasmablast responses in rhesus macaques: phenotypic characterization and a source for generating antigen-specific monoclonal antibodies | Q35071821 | ||
Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex | Q35132063 | ||
Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction | Q35709003 | ||
Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates | Q35849215 | ||
Human Anti-CD40 Antibody and Poly IC:LC Adjuvant Combination Induces Potent T Cell Responses in the Lung of Nonhuman Primates | Q35864569 | ||
Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults | Q36165265 | ||
Translating innate immunity into immunological memory: implications for vaccine development | Q36404657 | ||
Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology | Q36442817 | ||
Competence and competition: the challenge of becoming a long-lived plasma cell | Q36594883 | ||
Beyond antigens and adjuvants: formulating future vaccines | Q36618500 | ||
CXCL13 is a plasma biomarker of germinal center activity | Q36684710 | ||
Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination | Q36752092 | ||
TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis | Q37120117 | ||
Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection | Q37371463 | ||
Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer | Q37482035 | ||
Central Role of CD169+ Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01. | Q37519354 | ||
Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate | Q37587612 | ||
Molecular signatures of antibody responses derived from a systems biology study of five human vaccines | Q37625332 | ||
Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses | Q37718722 | ||
P433 | issue | 10 | |
P921 | main subject | malaria | Q12156 |
nanoparticle | Q61231 | ||
toll-like receptor | Q408004 | ||
malaria vaccine | Q6741353 | ||
P577 | publication date | 2018-05-17 | |
P1433 | published in | JCI insight | Q27727187 |
P1476 | title | TLR-adjuvanted nanoparticle vaccines differentially influence the quality and longevity of responses to malaria antigen Pfs25. | |
P478 | volume | 3 |
Q96137025 | A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates |
Q57295570 | A plug-and-play approach for malaria vaccination |
Q90699157 | Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment |
Q92710260 | BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications |
Q58120027 | Correlates of GLA family adjuvants' activities |
Q92234270 | ELISA units, IgG subclass ratio and avidity determined functional activity of mouse anti-Pfs230 antibodies judged by a standard membrane-feeding assay with Plasmodium falciparum |
Q92001627 | Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites |
Q64359404 | Peripheral follicular helper T cells in acute viral diseases: a perspective on dengue |
Q90261682 | Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25 |
Q56337913 | Progress toward a transmission-blocking vaccine against malaria |
Q90628348 | Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity |
Q90568060 | Shaping humoral immunity to vaccines through antigen-displaying nanoparticles |
Q84315417 | Viromimetic STING Agonist‐Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus |
Search more.